Trial Profile
A Randomized, Open Label, Multiple-Dose, Cross-over Clinical Study to Investigate Pharmacokinetics and Drug-Drug Interaction Between Rosuvastatin and CS-866 in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias; Hypercholesterolaemia; Hyperlipidaemia; Hypertension; Hypertriglyceridaemia
- Focus Pharmacodynamics; Pharmacokinetics
- 09 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
- 03 Apr 2012 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
- 03 Apr 2012 Actual end date (October 2011) added as reported by ClinicalTrials.gov.